Staphylococcus aureus vaccine(Escherichia Coli)
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 16, 2019 (NCT03966040)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Staphylococcus aureusImmunity, active
Staphylococcus aureus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03966040 | Phase 1 | May 16, 2019 | Chengdu Olymvax Biopharmaceuticals Inc., Government of China, People's Liberation Army of China |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chengdu Olymvax Biopharmaceuticals Inc. | For profit | 1 | 0 | 1 | 2019 |
| Government of China | Government | 1 | 1 | 1 | 2019 |
| People's Liberation Army of China | Government | 1 | 0 | 1 | 2019 |
3 organizations
Page 1 / 1